Developer of implantable sacral neuromodulation systems used to treat bladder and bowel dysfunction, including overactive bladder and urinary retention. Its devices compete in a niche but growing segment of the medical technology market historically dominated by larger players such as Medtronic. Inv...
No congressional trades have been disclosed for Axonics Inc (AXNX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.